
---
title: "0956 JNJ"
subtitle: "Stock Analysis by ChatGPT"
date: 2023-08-06T10:02:55
draft: true
tags: ['Johnson & Johnson', 'JNJ', 'Dividend King', 'Talc Lawsuits', 'Healthcare']
author: Friday Wall
---

score:956
### Chances:
1. Johnson & Johnson is part of the Zacks top Analyst Blog, which could attract investor attention.
2. JNJ is a longtime dividend payer and has earned the title of Dividend King, making it attractive to income-focused investors.
3. The company's involvement in appealing court appeals regarding talc-related claims may provide positive outcomes.
4. Johnson & Johnson's stock price might be favored by institutions due to their large stake in the company.
5. JNJ's consumer and healthcare brands, such as Band-Aid and Tylenol, can offer excellent opportunities for investors.
### Risks:
1. The Fitch Ratings' downgrade of U.S. credit may have an impact on the stock market, including Johnson & Johnson's stock.
2. The ongoing legal battles and cancer lawsuits related to JNJ's talc-based powders may lead to negative publicity and potential financial implications.
3. Market volatility and external factors may influence Johnson & Johnson's stock price and performance.
4. JNJ's total revenues during the second quarter missed the mark, which could be a concern for some investors.
5. The potential discount offered for shareholders to swap for shares of Kenvue may affect Johnson & Johnson's stock value.
### Score:956
chances characters count - risks characters count = -44

investment score = 1000 + chances characters count - risks characters count
### References:
- 2023-08-05 ['Oh my God': This secretary in Illinois built a $7M fortune starting with $180. The one powerful technique that made Grace Groner rich — and can change your life too](https://finance.yahoo.com/news/oh-god-secretary-illinois-built-130000868.html?.tsrc=rss)
- 2023-08-04 [Bruker (BRKR) Q2 Earnings and Revenues Top, '23 Sales View Up](https://finance.yahoo.com/news/bruker-brkr-q2-earnings-revenues-134500625.html?.tsrc=rss)
- 2023-08-04 [Better Buy: Johnson & Johnson vs. Proctor & Gamble](https://finance.yahoo.com/m/0a85ecbd-7e72-3ae9-a5cd-3f3f60f51811/better-buy%3A-johnson-%26-johnson.html?.tsrc=rss)
- 2023-08-04 [The Zacks Analyst Blog Highlights Johnson & Johnson, General Dynamics, Pioneer Natural Resources, Alibaba Group and Autodesk](https://finance.yahoo.com/news/zacks-analyst-blog-highlights-johnson-120800874.html?.tsrc=rss)
- 2023-08-04 [Itching for a Good Trade? Johnson & Johnson Spinoff Kenvue Should Offer Relief](https://finance.yahoo.com/m/3a78d96f-5650-35cd-bdbb-969abdfd9616/itching-for-a-good-trade%3F.html?.tsrc=rss)
- 2023-08-04 [Looking to Bet On Perfect AAA Credit Ratings? Play These ETFs](https://finance.yahoo.com/news/looking-bet-perfect-aaa-credit-171500242.html?.tsrc=rss)
- 2023-08-04 [Q2 Earnings Season Scorecard and Research Reports for JNJ, Pioneer Natural & Others](https://finance.yahoo.com/news/q2-earnings-season-scorecard-research-165900237.html?.tsrc=rss)
- 2023-08-03 [Sarepta (SRPT) Q2 Loss Narrower Than Expected, Sales Miss](https://finance.yahoo.com/news/sarepta-srpt-q2-loss-narrower-152800692.html?.tsrc=rss)
- 2023-08-03 [J&J’s $40 Billion Kenvue Stock Swap: What You Need to Know](https://finance.yahoo.com/m/fd432565-c83e-37da-9e5f-ed495640c1bf/j%26j%E2%80%99s-%2440-billion-kenvue.html?.tsrc=rss)
- 2023-08-03 [With 71% ownership of the shares, Johnson & Johnson (NYSE:JNJ) is heavily dominated by institutional owners](https://finance.yahoo.com/news/71-ownership-shares-johnson-johnson-120132672.html?.tsrc=rss)


                